S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
Log in
(Ad)
And Reuters magazine calls this type of trading "the new baby boomer hobby." An anonymous trader -- living at the base of the Smoky Mountains -- just released a free report revealing a step-by-step system to generating an extra $5,000 per month in income thanks to this trading strategy. The report is free until Sunday.

OTCMKTS:ENZN - Enzon Pharmaceuticals Stock Price, Forecast & News

$0.21
-0.01 (-4.55 %)
(As of 01/20/2020 10:11 AM ET)
Today's Range
$0.21
Now: $0.21
$0.23
50-Day Range
$0.20
MA: $0.21
$0.24
52-Week Range
$0.17
Now: $0.21
$0.31
Volume13,888 shs
Average Volume22,219 shs
Market Capitalization$9.29 million
P/E Ratio1.50
Dividend YieldN/A
Beta-0.03
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in licensing drug products. Its marketed drug products include PegIntron for use in the treatment of chronic hepatitis C; and Sylatron for use in the treatment of melanoma disease. The company was founded in 1981 and is headquartered in Cranford, New Jersey.

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryBiotechnology
SectorMedical
Current SymbolOTCMKTS:ENZN
Previous SymbolNASDAQ:ENZN
CUSIP29390410
Phone732-980-4500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$6.92 million
Cash Flow$0.13 per share
Book Value$0.34 per share

Profitability

Net Income$5.85 million

Miscellaneous

EmployeesN/A
Market Cap$9.29 million
Next Earnings Date2/20/2020 (Estimated)
OptionableNot Optionable

Receive ENZN News and Ratings via Email

Sign-up to receive the latest news and ratings for ENZN and its competitors with MarketBeat's FREE daily newsletter.


(Ad)


George Gilder has a shocking message for anybody with money in the bank, with a job that pays in dollars, or who carries a smartphone in their pocket. "Brace yourself," he says, "for the coming $16.8 trillion global 'reboot' ahead." It could change the way you get paid...change the way you save and invest for retirement.

Enzon Pharmaceuticals (OTCMKTS:ENZN) Frequently Asked Questions

What is Enzon Pharmaceuticals' stock symbol?

Enzon Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ENZN."

How were Enzon Pharmaceuticals' earnings last quarter?

Enzon Pharmaceuticals Inc (OTCMKTS:ENZN) released its quarterly earnings data on Wednesday, August, 10th. The biotechnology company reported $0.02 earnings per share (EPS) for the quarter. The biotechnology company earned $2.27 million during the quarter. View Enzon Pharmaceuticals' Earnings History.

When is Enzon Pharmaceuticals' next earnings date?

Enzon Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for Enzon Pharmaceuticals.

Has Enzon Pharmaceuticals been receiving favorable news coverage?

News headlines about ENZN stock have trended positive recently, InfoTrie reports. The research firm ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Enzon Pharmaceuticals earned a media sentiment score of 3.0 on InfoTrie's scale. They also assigned press coverage about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Enzon Pharmaceuticals.

Who are some of Enzon Pharmaceuticals' key competitors?

What other stocks do shareholders of Enzon Pharmaceuticals own?

Who are Enzon Pharmaceuticals' key executives?

Enzon Pharmaceuticals' management team includes the folowing people:
  • Mr. Andrew Rackear, CEO & Sec. (Age 65)
  • Mr. Richard L. Feinstein, VP of Fin. & CFO (Age 76)

How do I buy shares of Enzon Pharmaceuticals?

Shares of ENZN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Enzon Pharmaceuticals' stock price today?

One share of ENZN stock can currently be purchased for approximately $0.21.

How big of a company is Enzon Pharmaceuticals?

Enzon Pharmaceuticals has a market capitalization of $9.29 million and generates $6.92 million in revenue each year. View Additional Information About Enzon Pharmaceuticals.

What is Enzon Pharmaceuticals' official website?

The official website for Enzon Pharmaceuticals is http://www.enzon.com/.

How can I contact Enzon Pharmaceuticals?

Enzon Pharmaceuticals' mailing address is 20 Commerce Drive Suite 135, Cranford NJ, 07016. The biotechnology company can be reached via phone at 732-980-4500 or via email at [email protected]


MarketBeat Community Rating for Enzon Pharmaceuticals (OTCMKTS ENZN)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  91 (Vote Outperform)
Underperform Votes:  69 (Vote Underperform)
Total Votes:  160
MarketBeat's community ratings are surveys of what our community members think about Enzon Pharmaceuticals and other stocks. Vote "Outperform" if you believe ENZN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ENZN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel